Stock Split History
Lexicon Pharmaceuticals stock split history picture
Lexicon Pharmaceuticals (LXRX) has 1 split in our Lexicon Pharmaceuticals stock split history database. The split for LXRX took place on May 21, 2015. This was a 1 for 7 reverse split, meaning for each 7 shares of LXRX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split.

When a company such as Lexicon Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Lexicon Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 142.857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lexicon Pharmaceuticals shares, starting with a $10,000 purchase of LXRX, presented on a split-history-adjusted basis factoring in the complete Lexicon Pharmaceuticals stock split history. Lexicon Pharmaceuticals split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 03/27/2024
Start price/share: $12.11
End price/share: $2.19
Dividends collected/share: $0.00
Total return: -81.92%
Average Annual Total Return: -15.72%
Starting investment: $10,000.00
Ending investment: $1,809.04
Years: 10.00
Lexicon Pharmaceuticals is a biopharmaceutical company. Co. discovers the functions and pharmaceutical utility of genes and uses those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. Co. is also developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes. Co. is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain. In addition, Co. is conducting preclinical research and development and preparing to conduct clinical development of compounds from several additional drug programs. According to our Lexicon Pharmaceuticals stock split history records, Lexicon Pharmaceuticals has had 1 split.
Date Ratio
05/21/20151 for 7
LXRX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

MACK Split History
MBIO Split History
MBOT Split History
MBRX Split History
MBVX Split History
MCK Split History
MD Split History
MDCI Split History
MDGL Split History
MDGN Split History

Also explore: LXRX shares outstanding history

Email EnvelopeFree LXRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Pluri Inc. (PLUR)
Rent the Runway, Inc. (RENT)
Castor Maritime Inc. (CTRM)
ETAO International Co., Ltd. (ETAO)
Aterian, Inc. (ATER)
Chipotle Mexican Grill, Inc. (CMG)
Moleculin Biotech, Inc. (MBRX)
Longeveron Inc. (LGVN)
Intrusion Inc. (INTZ)
MicroSectorsTM Travel -3X Inverse Leveraged ETNs due May 29, 2042 (FLYD)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Lexicon Pharmaceuticals
Lexicon Pharmaceuticals Insider Buying

Lexicon Pharmaceuticals Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.